NYSE:NTR - Nutrien Stock Price, Forecast & News

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien declared a quarterly dividend on Monday, December 16th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.45 per share on Thursday, January 16th. This represents a $1.80 annualized dividend and a yield of 4.36%. The ex-dividend date of this dividend is Monday, December 30th. View Nutrien's Dividend History.

Nutrien Ltd (NYSE:NTR) issued its quarterly earnings results on Monday, November, 4th. The company reported $0.24 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by $0.12. The firm earned $4.13 billion during the quarter, compared to analyst estimates of $4.02 billion. Nutrien had a return on equity of 6.49% and a net margin of 20.95%. The business's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.47 EPS. View Nutrien's Earnings History.

Nutrien is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for Nutrien.

18 Wall Street analysts have issued 1-year target prices for Nutrien's shares. Their forecasts range from $47.00 to $70.00. On average, they anticipate Nutrien's stock price to reach $57.78 in the next year. This suggests a possible upside of 40.0% from the stock's current price. View Analyst Price Targets for Nutrien.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 8 hold ratings, 9 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nutrien.

News articles about NTR stock have been trending very negative this week, according to InfoTrie. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nutrien earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Nutrien.

Nutrien saw a increase in short interest in January. As of January 31st, there was short interest totalling 5,040,000 shares, an increase of 13.3% from the January 15th total of 4,450,000 shares. Based on an average trading volume of 1,300,000 shares, the days-to-cover ratio is presently 3.9 days. Approximately 0.9% of the company's stock are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include CF Industries (CF), Mosaic (MOS), Scotts Miracle-Gro (SMG), Israel Chemicals (ICL), Nufarm (NUF), American Vanguard (AVD), CVR Partners (UAN), Calyxt (CLXT), Marrone Bio Innovations (MBII), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), Eden Research (EDEN), China Green Agriculture (CGA) and Bion Environmental Technologies (BNET).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), AT&T (T), Cimarex Energy (XEC), Bank of America (BAC), Verizon Communications (VZ), Johnson & Johnson (JNJ), Exxon Mobil (XOM), Micron Technology (MU), Intel (INTC) and Pfizer (PFE).

Nutrien's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include First Eagle Investment Management LLC (3.90%), Jarislowsky Fraser Ltd (2.30%), Caisse DE Depot ET Placement DU Quebec (1.87%), FMR LLC (1.50%), TD Asset Management Inc. (1.28%) and Schroder Investment Management Group (1.10%).

NTR stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Connor Clark & Lunn Investment Management Ltd., Bank of New York Mellon Corp, Goldman Sachs Group Inc., Russell Investments Group Ltd., Great West Life Assurance Co. Can, Guardian Capital LP and Cambiar Investors LLC.

NTR stock was purchased by a variety of institutional investors in the last quarter, including Letko Brosseau & Associates Inc., Black Creek Investment Management Inc., First Eagle Investment Management LLC, Hexavest Inc., UBS Asset Management Americas Inc., Caisse DE Depot ET Placement DU Quebec, Alberta Investment Management Corp and Renaissance Technologies LLC.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $41.28.

Nutrien has a market capitalization of $23.65 billion and generates $19.64 billion in revenue each year. The company earns $3.57 billion in net income (profit) each year or $2.69 on an earnings per share basis. Nutrien employs 20,300 workers across the globe.View Additional Information About Nutrien.

The official website for Nutrien is http://www.nutrien.com/.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]